MedTrace Logo

Feasibility Clinical Investigation Using the InPress Device for the Treatment of Postpartum Hemorrhage

NCT04364386 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2024-09-19

Study results available
· View outcomes & findings →

Summary

Feasibility trial of the InPress Device to treat postpartum hemorrhage (PPH).

Conditions

  • Post Partum Hemorrhage

Interventions

DEVICE

InPress Device

Treatment with InPress Device for Postpartum Hemorrhage

Sponsors & Collaborators

  • Alydia Health

    lead INDUSTRY

Principal Investigators

  • Yuditiya Purwosunu, MD · Indonesia University

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-27
Primary Completion
2015-02-11
Completion
2015-04-01
FDA Device
Yes

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04364386 on ClinicalTrials.gov